Teva won a U.S. appeals court ruling that upheld three patents on its Ajovy migraine drug, though six other patents on the treatment were ruled invalid, according to a report.
The state has fully vaccinated 66.2% of its total population, including 76.5% of people aged 18 years old and older, according to the Centers for Disease Control and Prevention, as of July 9.